BG Medicine (BG Medicine) Total Inventories

: $0.15 Mil (As of Dec. 2015)

View and export this data going back to 2011. Start your Free Trial

BG Medicine's total inventories for the quarter that ended in Dec. 2015 was $0.15 Mil. BG Medicine's average total inventories from the quarter that ended in Sep. 2015 to the quarter that ended in Dec. 2015 was $0.18 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. BG Medicine's Net-Net Working Capital per share for the quarter that ended in Dec. 2015 was $-0.21.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. BG Medicine's Days Inventory for the three months ended in Dec. 2015 was 204.76.

Inventory Turnover measures how fast the company turns over its inventory within a year. BG Medicine's Inventory Turnover for the quarter that ended in Dec. 2015 was 0.45.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BG Medicine's Inventory-to-Revenue for the quarter that ended in Dec. 2015 was 0.63.

BG Medicine Total Inventories Historical Data

The historical data trend for BG Medicine's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BG Medicine Annual Data

Trend

Dec05

Dec06

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Total Inventories

0.21

0.45

0.46

0.40

0.15

BG Medicine Quarterly Data
	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15
Total Inventories																0.40	0.28	0.30	0.22	0.15

BG Medicine Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

BG Medicine (OTCPK:BGMD) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

BG Medicine's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2015 is

	Net-Net Working Capital Per Share (Q: Dec. 2015 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1.525	+	0.75 * 0.181	+	0.5 * 0.145	-	4.109
-	0	-	0)	/	11.3195
=	-0.21

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

BG Medicine's Days Inventory for the three months ended in Dec. 2015 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2015 )	/	Cost of Goods Sold (Q: Dec. 2015 )	*	Days in Period
	=	0.184	/	0.082	*	365 / 4
	=	204.76

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

BG Medicine's Inventory Turnover for the quarter that ended in Dec. 2015 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2015 )	/	Average Total Inventories (Q: Dec. 2015 )
	=	0.082	/	0.184
	=	0.45

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

BG Medicine's Inventory to Revenue for the quarter that ended in Dec. 2015 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2015 )	/	Revenue (Q: Dec. 2015 )
	=	0.184	/	0.29
	=	0.63

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

BG Medicine Total Inventories Related Terms

Thank you for viewing the detailed overview of BG Medicine's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

BG Medicine (BG Medicine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BG Medicine Inc (OTCPK:BGMD) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

303 Wyman Street, Suite 300, Waltham, MA, USA, 02451

Website

http://www.bg-medicine.com

BG Medicine Inc manufacture and sell diagnostic products that are used to guide the patients suffering from heart failure and related disorders in the United States. It distributes its products such as BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme-linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.

Executives

Jeffrey R Luber	director	100 CAMPUS DRIVE, C/O EXACT SCIENCES CORP, MARLBOROUGH MA 01752
Noubar Afeyan	director, 10 percent owner	C/O FLAGSHIP PIONEERING, INC., 55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE MA 02142
Stelios Papadopoulos	director	3 SOMERSET DRIVE SOUTH, GREAT NECK NY 11020
Harry W Wilcox	director	ONE KENDALL SQ, BLDG 700, CAMBRIDGE MA 02139
Agtc Partners, L.p.	10 percent owner	C/O FLAGSHIP VENTURES ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142
Newcogen Group, Inc.	10 percent owner	C/O FLAGSHIP VENTURES ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142
Applied Genomic Technology Capital Fund Lp	10 percent owner	C/O FLAGSHIP VENTURES ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142
Flagship Pioneering Inc.	10 percent owner	55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE MA 02142
Agtc Advisors Fund Lp	10 percent owner	ONE MEMORIAL DRIVE 7TH FLOOR CAMBRIDGE MA 02142
Kania Edwin M Jr	10 percent owner
Flagship Ventures Fund 2007, L.p.	10 percent owner	55 CAMBRIDGE PARKWAY, 8TH FLOOR, CAMBRIDGE MA 02142
Flagship Ventures 2007 General Partner Llc	10 percent owner	55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE MA 02142
Brian S Posner	director	14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Stephane Bancel	director	320 BENT STREET, CAMBRIDGE MA 02141
Harris Timothy J.r.	director	C/O BG MEDICINE, 610 LINCOLN STREET NORTH, WALTHAM MA 02451

BG Medicine (BG Medicine) Headlines

No Headlines